Eldelumab

• Target :

  CXCR

• Related Pathways :

  Immunology/Inflammation|||GPCR/G Protein|||Autophagy

• Purity :

  0.973

• Bioactivity :

  Eldelumab (BMS-936557) is a humanized anti-IP-10 IgG type 1 monoclonal antibody with inhibitory activity against CXCL10. It has anti-inflammatory properties, selectively binds to CXCL10, and can be used in the study of rheumatoid arthritis, ulcerative colitis, and Crohn's disease.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  946414-98-8